{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["7-\u03b1-hydroxyfrullanolide", "G2/M-phase arrest", "Grangea maderaspatana", "anticancer activity", "apoptosis", "proteomics", "sesquiterpene lactone", "triple-negative breast cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35056723", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "25"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "09"}], "Language": ["eng"], "ELocationID": ["407", "10.3390/molecules27020407"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "09"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Anticancer Effects and Molecular Action of 7-\u03b1-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells.", "Abstract": {"AbstractText": ["Triple negative breast cancer (TNBC) is a breast cancer subtype characterized by the absence of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression. TNBC cells respond poorly to targeted chemotherapies currently in use and the mortality rate of TNBC remains high. Therefore, it is necessary to identify new chemotherapeutic agents for TNBC. In this study, the anti-cancer effects of 7-\u03b1-hydroxyfrullanolide (7HF), derived from <i>Grangea maderaspatana</i>, on MCF-7, MDA-MB-231 and MDA-MB-468 breast cancer cells were assessed using MTT assay. The mode of action of 7HF in TNBC cells treated with 6, 12 and 24 \u00b5M of 7HF was determined by flow cytometry and propidium iodide (PI) staining for cell cycle analysis and annexin V/fluorescein isothiocyanate + PI staining for detecting apoptosis. The molecular mechanism of action of 7HF in TNBC cells was investigated by evaluating protein expression using proteomic techniques and western blotting. Subsequently, 7HF exhibited the strongest anti-TNBC activity toward MDA-MB-468 cells and a concomitantly weak toxicity toward normal breast cells. The molecular mechanism of action of low-dose 7HF in TNBC cells primarily involved G2/M-phase arrest through upregulation of the expression of Bub3, cyclin B1, phosphorylated Cdk1 (Tyr 15) and p53-independent p21. Contrastingly, the upregulation of PP2A-A subunit expression may have modulated the suppression of various cell survival proteins such as p-Akt (Ser 473), FoxO3a and \u03b2-catenin. The concurrent apoptotic effect of 7HF on the treated cells was mediated via both intrinsic and extrinsic modes through the upregulation of Bax and active cleaved caspase-7-9 expression and downregulation of Bcl-2 and full-length caspase-7-9 expression. Notably, the proteomic approach revealed the upregulation of the expression of pivotal protein clusters associated with G1/S-phase arrest, G2/M-phase transition and apoptosis. Thus, 7HF exhibits promising anti-TNBC activity and at a low dose, it modulates signal transduction associated with G2/M-phase arrest and apoptosis."]}, "AuthorList": [{"Identifier": ["0000-0002-2949-0467"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand."}], "LastName": "Chimplee", "ForeName": "Siriphorn", "Initials": "S"}, {"Identifier": ["0000-0003-3696-8390"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Functional Ingredients and Food Innovation Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand."}], "LastName": "Roytrakul", "ForeName": "Sittiruk", "Initials": "S"}, {"Identifier": ["0000-0003-4062-2632"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit of DNA Barcoding of Thai Medicinal Plants, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand."}], "LastName": "Sukrong", "ForeName": "Suchada", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Industrial Technology, Surat Thani Campus, Prince of Songkla University, Surat Thani 84000, Thailand."}, {"Identifier": [], "Affiliation": "Faculty of Innovative Agriculture and Fisheries, Surat Thani Campus, Prince of Songkla University, Surat Thani 84000, Thailand."}], "LastName": "Srisawat", "ForeName": "Theera", "Initials": "T"}, {"Identifier": ["0000-0002-9223-5282"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand."}], "LastName": "Graidist", "ForeName": "Potchanapond", "Initials": "P"}, {"Identifier": ["0000-0002-6765-0329"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand."}], "LastName": "Kanokwiroon", "ForeName": "Kanyanatt", "Initials": "K"}], "GrantList": [{"GrantID": "PHD/0091/2558", "Agency": "Royal Golden Jubilee Ph.D. (RGJ-PHD) Program, The National Research Council of Thailand (NRCT)", "Country": ""}, {"GrantID": "MED560604S", "Agency": "Prince of Songkla University Funding", "Country": ""}, {"GrantID": "REC57-0162-04-2", "Agency": "Research Fund of the Faculty of Medicine, Prince of Songkla University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Triple Negative Breast Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ferlay J., Colombet M., Soerjomataram I., Parkin D.M., Pineros M., Znaor A., Bray F. Cancer statistics for the year 2020: An overview. Int. J. Cancer. 2021 doi: 10.1002/ijc.33588.", "ArticleIdList": ["10.1002/ijc.33588", "33818764"]}, {"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;70:313. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Foulkes W.D., Smith I.E., Reis-Filho J.S. Triple-negative breast cancer. N. Engl. J. Med. 2010;363:1938\u20131948. doi: 10.1056/NEJMra1001389.", "ArticleIdList": ["10.1056/NEJMra1001389", "21067385"]}, {"Citation": "Hudis C.A., Gianni L. Triple-negative breast cancer: An unmet medical need. Oncologist. 2011;16:1\u201311. doi: 10.1634/theoncologist.2011-S1-01.", "ArticleIdList": ["10.1634/theoncologist.2011-S1-01", "21278435"]}, {"Citation": "Tao Z., Shi A., Lu C., Song T., Zhang Z., Zhao J. Breast cancer: Epidemiology and etiology. Cell Biochem. Biophys. 2015;72:333\u2013338. doi: 10.1007/s12013-014-0459-6.", "ArticleIdList": ["10.1007/s12013-014-0459-6", "25543329"]}, {"Citation": "Lee A., Djamgoz M.B.A. Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies. Cancer Treat. Rev. 2018;62:110\u2013122. doi: 10.1016/j.ctrv.2017.11.003.", "ArticleIdList": ["10.1016/j.ctrv.2017.11.003", "29202431"]}, {"Citation": "Wang C., Kar S., Lai X., Cai W., Arfuso F., Sethi G., Lobie P.E., Goh B.C., Lim L.H.K., Hartman M., et al. Triple negative breast cancer in Asia: An insider\u2019s view. Cancer Treat. Rev. 2018;62:29\u201338. doi: 10.1016/j.ctrv.2017.10.014.", "ArticleIdList": ["10.1016/j.ctrv.2017.10.014", "29154023"]}, {"Citation": "Liao G.S., Apaya M.K., Shyur L.F. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement. Altern. Med. 2013;2013:437948. doi: 10.1155/2013/437948.", "ArticleIdList": ["10.1155/2013/437948", "PMC3694462", "23840256"]}, {"Citation": "Sharma P. Biology and management of patients with triple-negative breast cancer. Oncologist. 2016;21:1050\u20131062. doi: 10.1634/theoncologist.2016-0067.", "ArticleIdList": ["10.1634/theoncologist.2016-0067", "PMC5016071", "27401886"]}, {"Citation": "Sharma P. Update on the treatment of early-stage triple-negative breast cancer. Curr. Treat. Options Oncol. 2018;19:22. doi: 10.1007/s11864-018-0539-8.", "ArticleIdList": ["10.1007/s11864-018-0539-8", "29656345"]}, {"Citation": "De Ruijter T.C., Veeck J., de Hoon J.P., van Engeland M., Tjan-Heijnen V.C. Characteristics of triple-negative breast cancer. J. Cancer Res. Clin. Oncol. 2011;137:183\u2013192. doi: 10.1007/s00432-010-0957-x.", "ArticleIdList": ["10.1007/s00432-010-0957-x", "PMC3018596", "21069385"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Nobili S., Lippi D., Witort E., Donnini M., Bausi L., Mini E., Capaccioli S. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 2009;59:365\u2013378. doi: 10.1016/j.phrs.2009.01.017.", "ArticleIdList": ["10.1016/j.phrs.2009.01.017", "19429468"]}, {"Citation": "Mahbubur-Rahman A.H.M. An ethnobotanical investigation on Asteraceae family at Rajshahi, Bangladesh. JBAMSR. 2013;2:92\u2013100."}, {"Citation": "Pandey A.K., Tripathi N.N. Diversity and distribution of aromatic plants in forests of Gorakhpur division, U.P., India. BFIJ. 2010;2:25\u201333."}, {"Citation": "Ruangrungsi N., Kasiwong S., Likhitwitayawuid K., Lange G.L., Decicco C.P. Constituents of Grangea maderaspatana. A new eudesmanolide. J. Nat. Prod. 1989;52:130\u2013134. doi: 10.1021/np50061a016.", "ArticleIdList": ["10.1021/np50061a016"]}, {"Citation": "Ahmed M., Islam M.M., Hossain C.F., Khan O.F. A preliminary study on the analgesic activity of Grangea maderaspatana. Fitoterapia. 2001;72:553\u2013554. doi: 10.1016/S0367-326X(00)00326-9.", "ArticleIdList": ["10.1016/S0367-326X(00)00326-9", "11429253"]}, {"Citation": "Patel V., Shukla S., Patel S. Free radical scavenging activity of Grangea maderaspatana (L.) Poir. Pharmacogn. Mag. 2009;5:381\u2013387."}, {"Citation": "Sangmalee S., Laorpaksa A., Sukrong S. A topoisomerase II poison screen of ethnomedicinal Thai plants using a yeast cell-based assay. J. Ethnopharmacol. 2012;142:432\u2013437. doi: 10.1016/j.jep.2012.05.013.", "ArticleIdList": ["10.1016/j.jep.2012.05.013", "22735665"]}, {"Citation": "Uppatanpreecha P. Topoisomerase I Inhibitory Activity from Thai Medicinal Plant in Yeast Cell-Based Assay. Chulalongkorn University; Bangkok, Thailand: 2009."}, {"Citation": "Rao V.M., Damu G.L.V., Sudhakar D., Rao C.V. Two new bio-active flavones from Grangea maderaspatana (Artemisia maderaspatana) Asian J. Chem. 2009;21:1552\u20131558."}, {"Citation": "Singh D., Mathela C.S., Pande V., Panwar A. Antioxidant and antimicrobial activity of Grangea maderaspatana (L.) Poir. extract. JDDT. 2013;1:46\u201352."}, {"Citation": "Ghantous A., Gali-Muhtasib H., Vuorela H., Saliba N.A., Darwiche N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov. Today. 2010;15:668\u2013678. doi: 10.1016/j.drudis.2010.06.002.", "ArticleIdList": ["10.1016/j.drudis.2010.06.002", "20541036"]}, {"Citation": "Babaei G., Aliarab A., Abroon S., Rasmi Y., Aziz S.G. Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity. Biomed. Pharmacother. 2018;106:239\u2013246. doi: 10.1016/j.biopha.2018.06.131.", "ArticleIdList": ["10.1016/j.biopha.2018.06.131", "29966966"]}, {"Citation": "Moujir L., Callies O., Sousa P.M.C., Sharopov F., Seca A.M.L. Applications of sesquiterpene lactones: A review of some potential success cases. Appl. Sci. 2020;10:3001. doi: 10.3390/app10093001.", "ArticleIdList": ["10.3390/app10093001"]}, {"Citation": "Wu Q.X., Shi Y.P., Jia Z.J. Eudesmane sesquiterpenoids from the Asteraceae family. Nat. Prod. Rep. 2006;23:699\u2013734. doi: 10.1039/b606168k.", "ArticleIdList": ["10.1039/b606168k", "17003906"]}, {"Citation": "Chimplee S., Graidist P., Srisawat T., Sukrong S., Bissanum R., Kanokwiroon K. Anti-breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis. Oncol. Lett. 2019;17:5283\u20135291. doi: 10.3892/ol.2019.10209.", "ArticleIdList": ["10.3892/ol.2019.10209", "PMC6507448", "31186745"]}, {"Citation": "Fonseca L.C., Dadarkar S.S., Lobo A.S., Suthar A.C., Chauhan V.S., Chandrababu S., Sharma S.D., Dagia N.M., Padigaru M. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation. Eur. J. Pharmacol. 2010;644:220\u2013229. doi: 10.1016/j.ejphar.2010.06.052.", "ArticleIdList": ["10.1016/j.ejphar.2010.06.052", "20621086"]}, {"Citation": "Srivastava R.A., Mistry S., Sharma S. A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes. Nutr. Metab. 2015;12:20. doi: 10.1186/s12986-015-0018-1.", "ArticleIdList": ["10.1186/s12986-015-0018-1", "PMC4462118", "26064179"]}, {"Citation": "Atta ur R., Choudhary M.I., Ata A., Alam M., Farooq A., Perveen S., Shekhani M.S., Ahmed N. Microbial Transformations of 7\u03b1-Hydroxyfrullanolide. J. Nat. Prod. 1994;57:1251\u20131255. doi: 10.1021/np50111a010.", "ArticleIdList": ["10.1021/np50111a010"]}, {"Citation": "Nahata A., Saxena A., Suri N., Saxena A.K., Dixit V.K. Sphaeranthus indicus induces apoptosis through mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic potential on several human cancer cell lines. Integr. Cancer Ther. 2013;12:236\u2013247. doi: 10.1177/1534735412451997.", "ArticleIdList": ["10.1177/1534735412451997", "22914874"]}, {"Citation": "Pandey P., Singh D., Hasanain M., Ashraf R., Maheshwari M., Choyal K., Singh A., Datta D., Kumar B., Sarkar J. 7-hydroxyfrullanolide, isolated from Sphaeranthus indicus, inhibits colorectal cancer cell growth by p53-dependent and -independent mechanism. Carcinogenesis. 2019;40:791\u2013804. doi: 10.1093/carcin/bgy176.", "ArticleIdList": ["10.1093/carcin/bgy176", "30535334"]}, {"Citation": "Abd Manaf A., Alitheen N.B., Mashitoh A.R., Shuhaimi M. Cytotoxic effect of damnacanthal, nordamnacanthal, zerumbone and betulinic acid isolated from Malaysian plant sources. Int. Food Res. J. 2010;17:711\u2013719."}, {"Citation": "Wibowo A., Ahmat N., Hamzah A.S., Sufian A.S., Ismail N.H., Ahmad R., Jaafar F.M., Takayama H., Malaysianol A. A new trimer resveratrol oligomer from the stem bark of Dryobalanops aromatica. Fitoterapia. 2011;82:676\u2013681. doi: 10.1016/j.fitote.2011.02.006.", "ArticleIdList": ["10.1016/j.fitote.2011.02.006", "21338657"]}, {"Citation": "Bezivin C., Tomasi S., Lohezic-Le Devehat F., Boustie J. Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomedicine Int. J. Phytother. Phytopharm. 2003;10:499\u2013503. doi: 10.1078/094471103322331458.", "ArticleIdList": ["10.1078/094471103322331458", "13678234"]}, {"Citation": "Prayong P., Barusrux S., Weerapreeyakul N. Cytotoxic activity screening of some indigenous Thai plants. Fitoterapia. 2008;79:598\u2013601. doi: 10.1016/j.fitote.2008.06.007.", "ArticleIdList": ["10.1016/j.fitote.2008.06.007", "18664377"]}, {"Citation": "Sebaugh J.L. Guidelines for accurate EC50/IC50 estimation. Pharm. Stat. 2011;10:128\u2013134. doi: 10.1002/pst.426.", "ArticleIdList": ["10.1002/pst.426", "22328315"]}, {"Citation": "Brooks E.A., Galarza S., Gencoglu M.F., Cornelison R.C., Munson J.M., Peyton S.R. Applicability of drug response metrics for cancer studies using biomaterials. Philos. Trans. R. Soc. B Biol. Sci. 2019;374:20180226. doi: 10.1098/rstb.2018.0226.", "ArticleIdList": ["10.1098/rstb.2018.0226", "PMC6627013", "31431182"]}, {"Citation": "Boik J. Natural Compounds in Cancer Therapy. Oregon Medical Press; Princeton, MN, USA: 2001."}, {"Citation": "Cordell G.A. Separation, structure elucidation, and bioassay of cytotoxic natural products. Bioact. Nat. Prod. Detect. Isol. Struct. Determ. 1993;197:195\u2013219."}, {"Citation": "Rosselli S., Bruno M., Raimondo F.M., Spadaro V., Varol M., Koparal A.T., Maggio A. Cytotoxic effect of eudesmanolides isolated from flowers of Tanacetum vulgare ssp. siculum. Molecules. 2012;17:8186\u20138195. doi: 10.3390/molecules17078186.", "ArticleIdList": ["10.3390/molecules17078186", "PMC6268150", "22777187"]}, {"Citation": "Lee K.H., Huang E.S., Piantadosi C., Pagano J.S., Geissman T.A. Cytotoxicity of sesquiterpene lactones. Cancer Res. 1971;31:1649\u20131654.", "ArticleIdList": ["4330633"]}, {"Citation": "Maldonado E.M., Svensson D., Oredsson S.M., Sterner O. Cytotoxic Sesquiterpene Lactones from Kauna Lasiophthalma Griseb. Sci. Pharm. 2014;82:147\u2013160. doi: 10.3797/scipharm.1310-18.", "ArticleIdList": ["10.3797/scipharm.1310-18", "PMC3951225", "24634851"]}, {"Citation": "Qin J.J., Wang W., Voruganti S., Wang H., Zhang W.D., Zhang R. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation. Oncotarget. 2015;6:2623\u20132640. doi: 10.18632/oncotarget.3098.", "ArticleIdList": ["10.18632/oncotarget.3098", "PMC4413606", "25739118"]}, {"Citation": "Fitzpatrick S.L., LaChance M.P., Schultz G.S. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res. 1984;44:3442\u20133447.", "ArticleIdList": ["6331647"]}, {"Citation": "Mueller K.L., Yang Z.Q., Haddad R., Ethier S.P., Boerner J.L. EGFR/Met association regulates EGFR TKI resistance in breast cancer. J. Mol. Signal. 2010;5:8. doi: 10.1186/1750-2187-5-8.", "ArticleIdList": ["10.1186/1750-2187-5-8", "PMC2911419", "20624308"]}, {"Citation": "Holliday D.L., Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011;13:215. doi: 10.1186/bcr2889.", "ArticleIdList": ["10.1186/bcr2889", "PMC3236329", "21884641"]}, {"Citation": "Changavi A.A., Shashikala A., Ramji A.S. Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas. J. Lab. Physicians. 2015;7:79\u201383. doi: 10.4103/0974-2727.163129.", "ArticleIdList": ["10.4103/0974-2727.163129", "PMC4559633", "26417156"]}, {"Citation": "Foidart P., Yip C., Radermacher J., Blacher S., Lienard M., Montero-Ruiz L., Maquoi E., Montaudon E., Chateau-Joubert S., Collignon J., et al. Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to 32 Erlotinib and Palbociclib Combination Therapy. Clin. Cancer Res. 2019;25:1838\u20131850. doi: 10.1158/1078-0432.CCR-18-1880.", "ArticleIdList": ["10.1158/1078-0432.CCR-18-1880", "30504427"]}, {"Citation": "Lindqvist A., Rodr\u00edguez-Bravo V., Medema R.H. The decision to enter mitosis: Feedback and redundancy in the mitotic entry network. J. Cell Biol. 2009;185:193\u2013202. doi: 10.1083/jcb.200812045.", "ArticleIdList": ["10.1083/jcb.200812045", "PMC2700378", "19364923"]}, {"Citation": "Doree M., Hunt T. From Cdc2 to Cdk1: When did the cell cycle kinase join its cyclin partner? J. Cell Sci. 2002;115:2461\u20132464. doi: 10.1242/jcs.115.12.2461.", "ArticleIdList": ["10.1242/jcs.115.12.2461", "12045216"]}, {"Citation": "Schmit T.L., Ahmad N. Regulation of mitosis via mitotic kinases: New opportunities for cancer management. Mol. Cancer Ther. 2007;6:1920. doi: 10.1158/1535-7163.MCT-06-0781.", "ArticleIdList": ["10.1158/1535-7163.MCT-06-0781", "17620424"]}, {"Citation": "Schmidt M., Rohe A., Platzer C., Najjar A., Erdmann F., Sippl W. Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases. Molecules. 2017;22:2045. doi: 10.3390/molecules22122045.", "ArticleIdList": ["10.3390/molecules22122045", "PMC6149964", "29168755"]}, {"Citation": "Ghelli Luserna di Ror\u00e0 A., Cerchione C., Martinelli G., Simonetti G. A WEE1 family business: Regulation of mitosis, cancer progression, and therapeutic target. J. Hematol. Oncol. 2020;13:126. doi: 10.1186/s13045-020-00959-2.", "ArticleIdList": ["10.1186/s13045-020-00959-2", "PMC7507691", "32958072"]}, {"Citation": "Lindqvist A., van Zon W., Karlsson Rosenthal C., Wolthuis R.M.F. Cyclin B1\u2013Cdk1 activation continues after centrosome separation to control mitotic progression. PLOS Biol. 2007;5:e123. doi: 10.1371/journal.pbio.0050123.", "ArticleIdList": ["10.1371/journal.pbio.0050123", "PMC1858714", "17472438"]}, {"Citation": "Liu S.T., Zhang H. The mitotic checkpoint complex (MCC): Looking back and forth after 15 years. AIMS Mol. Sci. 2016;3:597\u2013634. doi: 10.3934/molsci.2016.4.597.", "ArticleIdList": ["10.3934/molsci.2016.4.597", "PMC5597056", "28920074"]}, {"Citation": "Prinz F., Puetter V., Holton S.J., Andres D., Stegmann C.M., Kwiatkowski D., Prechtl S., Petersen K., Beckmann G., Kreft B., et al. Functional and structural characterization of Bub3.BubR1 interactions required for spindle assembly checkpoint signaling in human cells. J. Biol. Chem. 2016;291:11252\u201311267. doi: 10.1074/jbc.M115.702142.", "ArticleIdList": ["10.1074/jbc.M115.702142", "PMC4900272", "27030009"]}, {"Citation": "Sudakin V., Chan G.K., Yen T.J. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 2001;154:925\u2013936. doi: 10.1083/jcb.200102093.", "ArticleIdList": ["10.1083/jcb.200102093", "PMC2196190", "11535616"]}, {"Citation": "Tipton A.R., Tipton M., Yen T., Liu S.-T. Closed MAD2 (C-MAD2) is selectively incorporated into the mitotic checkpoint complex (MCC) Cell Cycle. 2011;10:3740\u20133750. doi: 10.4161/cc.10.21.17919.", "ArticleIdList": ["10.4161/cc.10.21.17919", "PMC3266009", "22037211"]}, {"Citation": "Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat. Rev. Cancer. 2009;9:153\u2013166. doi: 10.1038/nrc2602.", "ArticleIdList": ["10.1038/nrc2602", "19238148"]}, {"Citation": "Jackman M., Marcozzi C., Barbiero M., Pardo M., Yu L., Tyson A.L., Choudhary J.S., Pines J. Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint. J. Cell Biol. 2020;219:e201907082. doi: 10.1083/jcb.201907082.", "ArticleIdList": ["10.1083/jcb.201907082", "PMC7265330", "32236513"]}, {"Citation": "Han J.S., Vitre B., Fachinetti D., Cleveland D.W. Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling. Proc. Natl. Acad. Sci. USA. 2014;111:E4185. doi: 10.1073/pnas.1416277111.", "ArticleIdList": ["10.1073/pnas.1416277111", "PMC4210015", "25246557"]}, {"Citation": "Morais da Silva S., Moutinho-Santos T., Sunkel C.E. A tumor suppressor role of the Bub3 spindle checkpoint protein after apoptosis inhibition. J. Cell Biol. 2013;201:385\u2013393. doi: 10.1083/jcb.201210018.", "ArticleIdList": ["10.1083/jcb.201210018", "PMC3639401", "23609535"]}, {"Citation": "Lee K.H., Yim E.K., Kim C.J., Namkoong S.E., Um S.J., Park J.S. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol. Oncol. 2005;98:45\u201353. doi: 10.1016/j.ygyno.2005.04.010.", "ArticleIdList": ["10.1016/j.ygyno.2005.04.010", "15907983"]}, {"Citation": "Choi H.J., Fukui M., Zhu B.T. Role of Cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole. PLoS ONE. 2011;6:e24312. doi: 10.1371/journal.pone.0024312.", "ArticleIdList": ["10.1371/journal.pone.0024312", "PMC3168870", "21918689"]}, {"Citation": "Wang Y., Wang C., Jiang C., Zeng H., He X. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci. Rep. 2015;5:18613. doi: 10.1038/srep18613.", "ArticleIdList": ["10.1038/srep18613", "PMC4683523", "26678950"]}, {"Citation": "Agarwal C., Tyagi A., Agarwal R. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol. Cancer Ther. 2006;5:3294\u20133302. doi: 10.1158/1535-7163.MCT-06-0483.", "ArticleIdList": ["10.1158/1535-7163.MCT-06-0483", "17172433"]}, {"Citation": "Ma G., Chong L., Li Z., Cheung A.H., Tattersall M.H. Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro. Cancer Chemother. Pharmacol. 2009;64:143\u2013152. doi: 10.1007/s00280-008-0863-y.", "ArticleIdList": ["10.1007/s00280-008-0863-y", "18998133"]}, {"Citation": "Liu C.Y., Chang H.S., Chen I.S., Chen C.J., Hsu M.L., Fu S.L., Chen Y.J. Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells. Radiat. Oncol. 2011;6:56. doi: 10.1186/1748-717X-6-56.", "ArticleIdList": ["10.1186/1748-717X-6-56", "PMC3123574", "21624128"]}, {"Citation": "Liu Y., Chen X.Q., Liang H.X., Zhang F.X., Zhang B., Jin J., Chen Y.L., Cheng Y.X., Zhou G.B. Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLoS ONE. 2011;6:e21930. doi: 10.1371/journal.pone.0021930.", "ArticleIdList": ["10.1371/journal.pone.0021930", "PMC3130785", "21755010"]}, {"Citation": "Cotugno R., Fortunato R., Santoro A., Gallotta D., Braca A., De Tommasi N., Belisario M.A. Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe. Cell Prolif. 2012;45:53\u201365. doi: 10.1111/j.1365-2184.2011.00796.x.", "ArticleIdList": ["10.1111/j.1365-2184.2011.00796.x", "PMC6496441", "22168177"]}, {"Citation": "Bosco A., Molina L., Kern\u00e9is S.M., Hatzopoulos G., Favez T., G\u00f6nczy P., Tantapakul C., Maneerat W., Yeremy B., Williams D.E., et al. A sesquiterpene lactone from the Canadian prairie plant Gaillardia aristata inhibits mitosis in human cells. Mol. Biol. Rep. 2021;48:5459\u20135471. doi: 10.1007/s11033-021-06554-z.", "ArticleIdList": ["10.1007/s11033-021-06554-z", "34304367"]}, {"Citation": "Molina L., Williams D.E., Andersen R.J., Golsteyn R.M. Isolation of a natural product with anti-mitotic activity from a toxic Canadian prairie plant. Heliyon. 2021;7:e07131. doi: 10.1016/j.heliyon.2021.e07131.", "ArticleIdList": ["10.1016/j.heliyon.2021.e07131", "PMC8167235", "34095597"]}, {"Citation": "Karimian A., Ahmadi Y., Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair. 2016;42:63\u201371. doi: 10.1016/j.dnarep.2016.04.008.", "ArticleIdList": ["10.1016/j.dnarep.2016.04.008", "27156098"]}, {"Citation": "Choi Y.K., Seo H.S., Choi H.S., Choi H.S., Kim S.R., Shin Y.C., Ko S.-G. Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231. Mol. Cell. Biochem. 2012;363:119\u2013128. doi: 10.1007/s11010-011-1164-z.", "ArticleIdList": ["10.1007/s11010-011-1164-z", "22147197"]}, {"Citation": "Choi E.J., Ahn W.S. Antiproliferative effects of dehydrocostuslactone through cell cycle arrest and apoptosis in human ovarian cancer SK-OV-3 cells. Int. J. Mol. Med. 2009;23:211\u2013216.", "ArticleIdList": ["19148545"]}, {"Citation": "Caldas L.A., Horvath R.O., Ferreira-Silva G.A., Ferreira M.J.P., Ionta M., Sartorelli P., Calein C. A sesquiterpene lactone isolated from Calea Pinnatifida (Asteraceae), inhibits mitotic progression and induces apoptosis in MCF-7 Cells. Front. Pharmacol. 2018;9:1191. doi: 10.3389/fphar.2018.01191.", "ArticleIdList": ["10.3389/fphar.2018.01191", "PMC6201056", "30405412"]}, {"Citation": "Kouprina N., Pavlicek A., Collins N.K., Nakano M., Noskov V.N., Ohzeki J., Mochida G.H., Risinger J.I., Goldsmith P., Gunsior M., et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein. Hum. Mol. Genet. 2005;14:2155\u20132165. doi: 10.1093/hmg/ddi220.", "ArticleIdList": ["10.1093/hmg/ddi220", "15972725"]}, {"Citation": "Perrotti D., Neviani P. Protein phosphatase 2A: A target for anticancer therapy. Lancet Oncol. 2013;14:e229\u2013e238. doi: 10.1016/S1470-2045(12)70558-2.", "ArticleIdList": ["10.1016/S1470-2045(12)70558-2", "PMC3913484", "23639323"]}, {"Citation": "Reagan-Shaw S., Ahmad N. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: A target for the management of cancer. Toxicol. Appl. Pharmacol. 2007;224:360\u2013368. doi: 10.1016/j.taap.2006.12.003.", "ArticleIdList": ["10.1016/j.taap.2006.12.003", "17275054"]}, {"Citation": "Weidinger C., Krause K., Klagge A., Karger S., Fuhrer D. Forkhead box-O transcription factor: Critical conductors of cancer\u2019s fate. Endocr. Relat. Cancer. 2008;15:917\u2013929. doi: 10.1677/ERC-08-0153.", "ArticleIdList": ["10.1677/ERC-08-0153", "18775975"]}, {"Citation": "Wlodarchak N., Xing Y. PP2A as a master regulator of the cell cycle. Crit. Rev. Biochem. Mol. Biol. 2016;51:162\u2013184. doi: 10.3109/10409238.2016.1143913.", "ArticleIdList": ["10.3109/10409238.2016.1143913", "PMC4905575", "26906453"]}, {"Citation": "Das T.P., Suman S., Alatassi H., Ankem M.K., Damodaran C. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer. Cell Death Dis. 2016;7:e2111. doi: 10.1038/cddis.2015.403.", "ArticleIdList": ["10.1038/cddis.2015.403", "PMC4849149", "26913603"]}, {"Citation": "Jin G.S., Kondo E., Miyake T., Shibata M., Takashima T., Liu Y.X., Hayashi K., Akagi T., Yoshino T. Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. Acta Med. Okayama. 2004;58:197\u2013205.", "ArticleIdList": ["15551757"]}, {"Citation": "P\u00e9rez-Tenorio G., St\u00e5l O., Members of the Southeast Sweden Breast Cancer Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br. J. Cancer. 2002;86:540\u2013545. doi: 10.1038/sj.bjc.6600126.", "ArticleIdList": ["10.1038/sj.bjc.6600126", "PMC2375266", "11870534"]}, {"Citation": "Dai D.L., Martinka M., Li G. Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases. J. Clin. Oncol. 2005;23:1473\u20131482. doi: 10.1200/JCO.2005.07.168.", "ArticleIdList": ["10.1200/JCO.2005.07.168", "15735123"]}, {"Citation": "Safdari Y., Khalili M., Ebrahimzadeh M.A., Yazdani Y., Farajnia S. Natural inhibitors of PI3K/AKT signaling in breast cancer: Emphasis on newly-discovered molecular mechanisms of action. Pharmacol. Res. 2015;93:1\u201310. doi: 10.1016/j.phrs.2014.12.004.", "ArticleIdList": ["10.1016/j.phrs.2014.12.004", "25533812"]}, {"Citation": "Noori S., Hassan Z.M. Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis. Free Radic. Biol. Med. 2012;52:1987\u20131999. doi: 10.1016/j.freeradbiomed.2012.01.026.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.01.026", "22366652"]}, {"Citation": "Storz P. Forkhead Homeobox Type O transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2010;14:593\u2013605. doi: 10.1089/ars.2010.3405.", "ArticleIdList": ["10.1089/ars.2010.3405", "PMC3038124", "20618067"]}, {"Citation": "Eichhorn P.J., Creyghton M.P., Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta. 2009;1795:1\u201315. doi: 10.1016/j.bbcan.2008.05.005.", "ArticleIdList": ["10.1016/j.bbcan.2008.05.005", "18588945"]}, {"Citation": "Seshacharyulu P., Pandey P., Datta K., Batra S.K. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett. 2013;335:9\u201318. doi: 10.1016/j.canlet.2013.02.036.", "ArticleIdList": ["10.1016/j.canlet.2013.02.036", "PMC3665613", "23454242"]}, {"Citation": "Shang S., Hua F., Hu Z.W. The regulation of beta-catenin activity and function in cancer: Therapeutic opportunities. Oncotarget. 2017;8:33972\u201333989. doi: 10.18632/oncotarget.15687.", "ArticleIdList": ["10.18632/oncotarget.15687", "PMC5464927", "28430641"]}, {"Citation": "Yu W.-K., Xu Z.-Y., Yuan L., Mo S., Xu B., Cheng X.-D., Qin J.-J. Targeting \u03b2-catenin signaling by natural products for cancer prevention and therapy. Front. Pharmacol. 2020;11:984. doi: 10.3389/fphar.2020.00984.", "ArticleIdList": ["10.3389/fphar.2020.00984", "PMC7338604", "32695004"]}, {"Citation": "Fulda S., Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25:4798\u20134811. doi: 10.1038/sj.onc.1209608.", "ArticleIdList": ["10.1038/sj.onc.1209608", "16892092"]}, {"Citation": "Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337.", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Burz C., Berindan-Neagoe I., Balacescu O., Irimie A. Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol. 2009;48:811\u2013821. doi: 10.1080/02841860902974175.", "ArticleIdList": ["10.1080/02841860902974175", "19513886"]}, {"Citation": "Walsh J.G., Cullen S.P., Sheridan C., L\u00fcthi A.U., Gerner C., Martin S.J. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc. Natl. Acad. Sci. USA. 2008;105:12815. doi: 10.1073/pnas.0707715105.", "ArticleIdList": ["10.1073/pnas.0707715105", "PMC2529079", "18723680"]}, {"Citation": "Wang Y., Zhong J., Bai J., Tong R., An F., Jiao P., He L., Zeng D., Long E., Yan J., et al. The application of natural products in cancer therapy by targeting apoptosis pathways. Curr. Drug Metab. 2018;19:739\u2013749. doi: 10.2174/1389200219666180511154722.", "ArticleIdList": ["10.2174/1389200219666180511154722", "29749309"]}, {"Citation": "Barnum K.J., O\u2019Connell M.J. Cell cycle regulation by checkpoints. Methods Mol. Biol. 2014;1170:29\u201340.", "ArticleIdList": ["PMC4990352", "24906307"]}, {"Citation": "Pietenpol J.A., Stewart Z.A. Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis. Toxicology. 2002;181:475\u2013481. doi: 10.1016/S0300-483X(02)00460-2.", "ArticleIdList": ["10.1016/S0300-483X(02)00460-2", "12505356"]}, {"Citation": "Lacroix M., Toillon R.A., Leclercq G. p53 and breast cancer, an update. Endocr. Relat. Cancer. 2006;13:293\u2013325. doi: 10.1677/erc.1.01172.", "ArticleIdList": ["10.1677/erc.1.01172", "16728565"]}, {"Citation": "Ozaki T., Nakagawara A. Role of p53 in cell death and human cancers. Cancers. 2011;3:994\u20131013. doi: 10.3390/cancers3010994.", "ArticleIdList": ["10.3390/cancers3010994", "PMC3756401", "24212651"]}, {"Citation": "Avni D., Yang H., Martelli F., Hofmann F., ElShamy W.M., Ganesan S., Scully R., Livingston D.M. Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. Mol. Cell. 2003;12:735\u2013746. doi: 10.1016/S1097-2765(03)00355-1.", "ArticleIdList": ["10.1016/S1097-2765(03)00355-1", "14527418"]}, {"Citation": "Magenta A., Fasanaro P., Romani S., Di Stefano V., Capogrossi M.C., Martelli F. Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol. Cell Biol. 2008;28:873\u2013882. doi: 10.1128/MCB.00480-07.", "ArticleIdList": ["10.1128/MCB.00480-07", "PMC2223420", "17991896"]}, {"Citation": "Ji P., Jiang H., Rekhtman K., Bloom J., Ichetovkin M., Pagano M., Zhu L. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell. 2004;16:47\u201358. doi: 10.1016/j.molcel.2004.09.029.", "ArticleIdList": ["10.1016/j.molcel.2004.09.029", "15469821"]}, {"Citation": "Michishita E., McCord R.A., Boxer L.D., Barber M.F., Hong T., Gozani O., Chua K.F. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle. 2009;8:2664\u20132666. doi: 10.4161/cc.8.16.9367.", "ArticleIdList": ["10.4161/cc.8.16.9367", "PMC4474138", "19625767"]}, {"Citation": "Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492\u2013496. doi: 10.1038/nature06736.", "ArticleIdList": ["10.1038/nature06736", "PMC2646112", "18337721"]}, {"Citation": "Margolis S.S., Perry J.A., Forester C.M., Nutt L.K., Guo Y., Jardim M.J., Thomenius M.J., Freel C.D., Darbandi R., Ahn J.H., et al. Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell. 2006;127:759\u2013773. doi: 10.1016/j.cell.2006.10.035.", "ArticleIdList": ["10.1016/j.cell.2006.10.035", "PMC2789796", "17110335"]}, {"Citation": "Kohama Y., Saito M., Yada M., Sakurai H. Regulation of the stability and activity of CDC25A and CDC25B by protein phosphatase PP2A and 14-3-3 binding. Cell Signal. 2019;54:10\u201316. doi: 10.1016/j.cellsig.2018.11.017.", "ArticleIdList": ["10.1016/j.cellsig.2018.11.017", "30468767"]}, {"Citation": "Brandwein D., Wang Z. Interaction between Rho GTPases and 14-3-3 Proteins. Int. J. Mol. Sci. 2017;18:2148. doi: 10.3390/ijms18102148.", "ArticleIdList": ["10.3390/ijms18102148", "PMC5666830", "29036929"]}, {"Citation": "Compton D.A., Luo C. Mutation of the predicted p34cdc2 phosphorylation sites in NuMA impair the assembly of the mitotic spindle and block mitosis. J. Cell Sci. 1995;108:621\u2013633. doi: 10.1242/jcs.108.2.621.", "ArticleIdList": ["10.1242/jcs.108.2.621", "7769006"]}, {"Citation": "Carazo-Salas R.E., Guarguaglini G., Gruss O.J., Segref A., Karsenti E., Mattaj I.W. Generation of GTP-bound Ran by RCC1 is required for chromatin-induced mitotic spindle formation. Nature. 1999;400:178\u2013181. doi: 10.1038/22133.", "ArticleIdList": ["10.1038/22133", "10408446"]}, {"Citation": "Hauf S., Waizenegger I.C., Peters J.M. Cohesin cleavage by separase required for anaphase and cytokinesis in human cells. Science. 2001;293:1320\u20131323. doi: 10.1126/science.1061376.", "ArticleIdList": ["10.1126/science.1061376", "11509732"]}, {"Citation": "Kimura K., Cuvier O., Hirano T. Chromosome condensation by a human condensin complex in Xenopus egg extracts. J. Biol. Chem. 2001;276:5417\u20135420. doi: 10.1074/jbc.C000873200.", "ArticleIdList": ["10.1074/jbc.C000873200", "11136719"]}, {"Citation": "Gruneberg U., Neef R., Li X., Chan E.H., Chalamalasetty R.B., Nigg E.A., Barr F.A. KIF14 and citron kinase act together to promote efficient cytokinesis. J. Cell Biol. 2006;172:363\u2013372. doi: 10.1083/jcb.200511061.", "ArticleIdList": ["10.1083/jcb.200511061", "PMC2063646", "16431929"]}, {"Citation": "Bao X., Liu H., Liu X., Ruan K., Zhang Y., Zhang Z., Hu Q., Liu Y., Akram S., Zhang J., et al. Mitosis-specific acetylation tunes Ran effector binding for chromosome segregation. J. Mol. Cell Biol. 2018;10:18\u201332. doi: 10.1093/jmcb/mjx045.", "ArticleIdList": ["10.1093/jmcb/mjx045", "PMC6041754", "29040603"]}, {"Citation": "Jiang K., Rezabkova L., Hua S., Liu Q., Capitani G., Altelaar A.F.M., Heck A.J.R., Kammerer R.A., Steinmetz M.O., Akhmanova A. Microtubule minus-end regulation at spindle poles by an ASPM-katanin complex. Nat. Cell Biol. 2017;19:480\u2013492. doi: 10.1038/ncb3511.", "ArticleIdList": ["10.1038/ncb3511", "PMC5458804", "28436967"]}, {"Citation": "Ren Y., Li R., Zheng Y., Busch H. Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases. J. Biol. Chem. 1998;273:34954\u201334960. doi: 10.1074/jbc.273.52.34954.", "ArticleIdList": ["10.1074/jbc.273.52.34954", "9857026"]}, {"Citation": "Birkenfeld J., Nalbant P., Yoon S.H., Bokoch G.M. Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: Is altered GEF-H1 activity a crucial determinant of disease pathogenesis? Trends Cell Biol. 2008;18:210\u2013219. doi: 10.1016/j.tcb.2008.02.006.", "ArticleIdList": ["10.1016/j.tcb.2008.02.006", "18394899"]}, {"Citation": "Sandi M.J., Marshall C.B., Balan M., Coyaud E., Zhou M., Monson D.M., Ishiyama N., Chandrakumar A.A., La Rose J., Couzens A.L., et al. MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity. Sci. Signal. 2017;10:eaan3286. doi: 10.1126/scisignal.aan3286.", "ArticleIdList": ["10.1126/scisignal.aan3286", "PMC6504561", "29089450"]}, {"Citation": "Saffin J.M., Venoux M., Prigent C., Espeut J., Poulat F., Giorgi D., Abrieu A., Rouquier S. ASAP, a human microtubule-associated protein required for bipolar spindle assembly and cytokinesis. Proc. Natl. Acad. Sci. USA. 2005;102:11302\u201311307. doi: 10.1073/pnas.0500964102.", "ArticleIdList": ["10.1073/pnas.0500964102", "PMC1183541", "16049101"]}, {"Citation": "Liao S., Rajendraprasad G., Wang N., Eibes S., Gao J., Yu H., Wu G., Tu X., Huang H., Barisic M., et al. Molecular basis of vasohibins-mediated detyrosination and its impact on spindle function and mitosis. Cell Res. 2019;29:533\u2013547. doi: 10.1038/s41422-019-0187-y.", "ArticleIdList": ["10.1038/s41422-019-0187-y", "PMC6796878", "31171830"]}, {"Citation": "Tarze A., Deniaud A., Le Bras M., Maillier E., Molle D., Larochette N., Zamzami N., Jan G., Kroemer G., Brenner C. GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene. 2007;26:2606\u20132620. doi: 10.1038/sj.onc.1210074.", "ArticleIdList": ["10.1038/sj.onc.1210074", "17072346"]}, {"Citation": "Ghavami S., Eshragi M., Ande S.R., Chazin W.J., Klonisch T., Halayko A.J., McNeill K.D., Hashemi M., Kerkhoff C., Los M. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 2010;20:314\u2013331. doi: 10.1038/cr.2009.129.", "ArticleIdList": ["10.1038/cr.2009.129", "PMC4161879", "19935772"]}, {"Citation": "Martin D.D., Heit R.J., Yap M.C., Davidson M.W., Hayden M.R., Berthiaume L.G. Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin. Hum. Mol. Genet. 2014;23:3166\u20133179. doi: 10.1093/hmg/ddu027.", "ArticleIdList": ["10.1093/hmg/ddu027", "PMC4030772", "24459296"]}, {"Citation": "Nguyen M., Breckenridge D.G., Ducret A., Shore G.C. Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol. Cell Biol. 2000;20:6731\u20136740. doi: 10.1128/MCB.20.18.6731-6740.2000.", "ArticleIdList": ["10.1128/MCB.20.18.6731-6740.2000", "PMC86192", "10958671"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "30"}, {"Year": "2021", "Month": "12", "Day": "29"}, {"Year": "2022", "Month": "1", "Day": "6"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "1", "Minute": "15"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["35056723", "PMC8779136", "10.3390/molecules27020407", "molecules27020407"]}}], "PubmedBookArticle": []}